Mochida Pharmaceutical Overview

  • Founded
  • 1913

Founded
  • Status
  • Public

  • Employees
  • 2,047

Employees
  • Stock Symbol
  • 4534

Stock Symbol
  • Investments
  • 2

  • Share Price
  • $23.36

  • (As of Friday Closing)

Mochida Pharmaceutical General Information

Description

Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
TKS
Primary Office
  • 1-7, Yotsuya
  • Tokyo, Shinjuku-Ku 160-8515
  • Japan
+81 00-0000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mochida Pharmaceutical Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$23.36 $23.41 $22.22 - $33.84 $874M 37.4M 39.8K $2.49

Mochida Pharmaceutical Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020
EV 390,761 621,983 905,933 980,524
Revenue 941,637 980,735 971,289 936,252
EBITDA 153,797 138,052 82,781
Net Income 94,335 94,078 80,979 42,287
Total Assets 1,188,607 1,336,679 1,466,619 1,457,236
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Mochida Pharmaceutical Patents

Mochida Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2022097087-A Composition for external use containing tranexamic acid Pending 18-Dec-2020
US-20220193118-A1 Method for suppressing intervertebral disc pain Pending 13-Nov-2020 000000000
JP-2021008518-A Self-emulsifying composition of ω-3 fatty acid Pending 21-Oct-2020 0
US-20210379004-A1 Method for preventing occurrence of cardiovascular event in multiple risk patient Inactive 03-Jun-2020 00000000
JP-2021109006-A Injection device Active 14-Jan-2020
To view Mochida Pharmaceutical’s complete patent history, request access »

Mochida Pharmaceutical Executive Team (3)

Name Title Board Seat Contact Info
Keiichi Sagisaka Board Member & Executive
Kiyoshi Mizuguchi Board Member & Executive
Chu Sakata Board Member & Senior Executive Vice President
To view Mochida Pharmaceutical’s complete executive team members history, request access »

Mochida Pharmaceutical Board Members (4)

Name Representing Role Since
000 000000 Mochida Pharmaceutical Board Member & Senior Executive Vice President 000 0000
0000000 00000000 Mochida Pharmaceutical Board Member & Executive 000 0000
0000000 000000000 Mochida Pharmaceutical Board Member & Executive 000 0000
00000 00000000 Mochida Pharmaceutical Board Member 000 0000
To view Mochida Pharmaceutical’s complete board members history, request access »

Mochida Pharmaceutical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mochida Pharmaceutical Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 29-Mar-2022 00000 0000 00.000 Discovery Tools (Healthcare)
Mochida Siemens Medical Systems 01-Jan-2004 Joint Venture Diagnostic Equipment
To view Mochida Pharmaceutical’s complete investments history, request access »